Related Experiment Video
Updated: Jul 5, 2026

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
Published on: May 24, 2012
[Lentiviral vectors and advance in its application]
Bo Chu1, Xuefeng Huang, Yunming Tang
1School of Life Science of Southwest University, Chongqing 400715, China.
Lentiviral vectors (Lv) are versatile tools for gene therapy, enabling efficient gene delivery to various cell types. This review explores their characteristics, development, and applications, highlighting their potential in therapeutic strategies.
Area of Science:
- Gene Therapy
- Molecular Biology
- Virology
Context:
- Lentiviral vectors (Lv) are a prominent research area in gene therapy due to their advantageous properties.
- These properties include efficient transduction of both dividing and non-dividing cells, large gene transfer capacity, and sustained gene expression.
- A low rate of immunological response further enhances their therapeutic potential.
Purpose:
- To review the fundamental characteristics of lentiviral vectors (Lv).
- To discuss the developmental advancements in Lv technology.
- To explore the current and emerging applications of Lv in gene therapy.
Summary:
- This review focuses on lentiviral vectors (Lv), particularly those derived from HIV-1.
- It details their structural features, evolutionary progress, and diverse applications in the field of gene therapy.
- Key aspects covered include transduction efficiency, gene capacity, expression duration, and immunogenicity.
Impact:
- Lentiviral vectors (Lv) represent a significant platform for developing novel gene therapies.
- Understanding their characteristics and applications is crucial for advancing therapeutic strategies.
- This review provides a comprehensive overview for researchers and clinicians in the gene therapy domain.
More Related Videos
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
11:08Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
Published on: April 8, 2012